CAMK2G and heart failure: Given the extensive structural and electrophysiological remodeling accompanying heart failure, and relatively poor specificity of small molecule inhibitors available for in vivo CaMKII blockade, it is still not entirely clear how effective acute CaMKII inhibition may be as an anti-arrhythmic strategy in heart failure.